Commonwealth Coat of Arms of Australia

 

 

PB 92 of 2025

National Health (Price and Special Patient Contribution) Amendment Determination (No. 7) 2025

I, Rebecca Richardson, Assistant Secretary, PBS Listing, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make the following Determination:

Dated 28 July 2025

REBECCA RICHARDSON

Assistant Secretary

PBS Listing, Pricing and Policy Branch

Technology Assessment and Access Division

Department of Health, Disability and Ageing

1  Name...................................................1

2  Commencement............................................1

3  Authority................................................1

4  Schedules................................................1

Schedule 1—Amendments 2

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) 2

 

  This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination (No. 7) 2025.

  This instrument may also be cited as PB 92 of 2025.

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 August 2025

 

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

  This instrument is made under section 85B of the National Health Act 1953.

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1 – Amendments
 

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)

  1.                 Schedule 1 – entry for Amlodipine with atorvastatin

Omit

Amlodipine with atorvastatin

Tablet 5 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium)

Oral

Caduet 5/40

30

3.78

8.43

 

Tablet 5 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium)

Oral

Caduet 5/80

30

5.05

9.70

 

Tablet 10 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium)

Oral

Caduet 10/10

30

3.39

8.04

 

Tablet 10 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium)

Oral

Caduet 10/20

30

3.57

8.22

 

Tablet 10 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium)

Oral

Caduet 10/40

30

4.42

9.07

 

Tablet 10 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium)

Oral

Caduet 10/80

30

5.69

10.34

Insert

Amlodipine with atorvastatin

Tablet 5 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium)

Oral

Caduet 5/80

30

5.05

9.70

 

Tablet 10 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium)

Oral

Caduet 10/10

30

3.39

8.04

 

Tablet 10 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium)

Oral

Caduet 10/20

30

3.57

8.22

 

Tablet 10 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium)

Oral

Caduet 10/40

30

4.42

9.07

 

Tablet 10 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium)

Oral

Caduet 10/80

30

5.69

10.34

  1.                 Schedule 1 – entry for Codeine with paracetamol

Omit

Codeine with paracetamol

Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg

Oral

Panadeine Forte

20

2.50

5.78

 

Insert

Codeine with paracetamol

Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg

Oral

Panadeine Forte

20

2.50

6.28

  1.                 Schedule 1 – entry for Dosulepin

Omit

Dosulepin

Tablet containing dosulepin hydrochloride 25 mg

Oral

Dothep 25

50

2.89

4.70

 

Insert

Dosulepin

Tablet containing dosulepin hydrochloride 25 mg

Oral

Dothep 25

50

2.89

4.70

 

Tablet containing dosulepin hydrochloride 75 mg

Oral

Dothep 75

50

2.89

4.70

  1.                 Schedule 1 – entry after Ezetimibe and rosuvastatin

Insert

Ezetimibe with atorvastatin

Tablet 10 mg-40 mg

Oral

Atozet

30

10.33

12.40

 

  1.                 Schedule 1 – entry after Furosemide

Insert

Gabapentin

Capsule 100 mg

Oral

Neurontin

100

3.76

5.92

 

Capsule 300 mg

Oral

Neurontin

100

8.97

11.01

 

Capsule 400 mg

Oral

Neurontin

100

12.23

14.28

 

Tablet 600 mg

Oral

Neurontin

100

19.16

21.21

  1.                 Schedule 1 – entry for Irbesartan

Omit

Irbesartan

Tablet 150 mg

Oral

Avapro

30

2.50

5.78

 

 

 

Karvea

30

2.50

5.78

 

Tablet 300 mg

Oral

Avapro

30

3.50

6.75

 

 

 

Karvea

30

3.50

6.75

 

Insert

Irbesartan

Tablet 150 mg

Oral

Avapro

30

2.50

6.28

 

 

 

Karvea

30

2.50

6.28

 

Tablet 300 mg

Oral

Avapro

30

3.50

7.25

 

 

 

Karvea

30

3.50

7.25

  1.                 Schedule 1 – entry for Irbesartan with hydrochlorothiazide

Omit

Irbesartan with hydrochlorothiazide

Tablet 150 mg‑12.5 mg

Oral

Avapro HCT 150/12.5

30

2.50

5.78

 

 

 

Karvezide 150/12.5

30

2.50

5.78

 

Tablet 300 mg‑12.5 mg

Oral

Avapro HCT 300/12.5

30

3.60

6.85

 

 

 

Karvezide 300/12.5

30

3.60

6.85

 

Tablet 300 mg‑25 mg

Oral

Avapro HCT 300/25

30

3.92

7.17

 

 

 

Karvezide 300/25

30

3.92

7.17

Insert

Irbesartan with hydrochlorothiazide

Tablet 150 mg‑12.5 mg

Oral

Avapro HCT 150/12.5

30

2.50

6.28

 

 

 

Karvezide 150/12.5

30

2.50

6.28

 

Tablet 300 mg‑12.5 mg

Oral

Avapro HCT 300/12.5

30

3.60

7.35

 

 

 

Karvezide 300/12.5

30

3.60

7.35

 

Tablet 300 mg‑25 mg

Oral

Avapro HCT 300/25

30

3.92

7.67

 

 

 

Karvezide 300/25

30

3.92

7.67

  1.                 Schedule 1 – entry after Oxycodone

Insert

Pantoprazole

Tablet (enteric coated) 20 mg (as sodium sesquihydrate)

Oral

Somac

30

2.50

7.12

 

Tablet (enteric coated) 40 mg (as sodium sesquihydrate)

Oral

Somac

30

2.87

7.48